Lorna McLeod

Latest from Lorna McLeod

Special Report on Process- and Product-Related Impurities (A CMC Strategy Forum Special Focus Series): Extractables, Leachables, Particles, and
CMC Forums
Special Report on Process- and Product-Related Impurities (A CMC Strategy Forum Special Focus Series): Extractables, Leachables, Particles, and AggregatesSpecial Report on Process- and Product-Related Impurities (A CMC Strategy Forum Special Focus Series): Extractables, Leachables, Particles, and Aggregates
byAnthony Mire-Sluis, Stacey Maand 3 more
Nov 17, 2016
Uniting Small-Molecule and Biologic Drug Perspectives: Analytical Characterization and Regulatory Considerations for Antibody–Drug Conjugates
Emerging Therapeutics
Uniting Small-Molecule and Biologic Drug Perspectives: Analytical Characterization and Regulatory Considerations for Antibody–Drug ConjugatesUniting Small-Molecule and Biologic Drug Perspectives: Analytical Characterization and Regulatory Considerations for Antibody–Drug Conjugates
byLorna McLeod, Jon Harrisand 4 more
Sep 23, 2015

All from Lorna McLeod

Glycosylation of Therapeutic Proteins: Current Understanding of Structure–Function Relationships logo in a gray background | Glycosylation of Therapeutic Proteins: Current Understanding of Structure–Function Relationships
Product Characterization
Glycosylation of Therapeutic Proteins: Current Understanding of Structure–Function Relationships
Glycosylation of Therapeutic Proteins: Current Understanding of Structure–Function Relationships
Sep 23, 2015
+4
byJoseph Siemiatkoski, Stacey Maand 4 more
Raw Material Control Strategies for Bioprocesses logo in a gray background | Raw Material Control Strategies for Bioprocesses
CMC Forums
Raw Material Control Strategies for Bioprocesses
Raw Material Control Strategies for Bioprocesses
Apr 14, 2015
+5
byGregory Beck, Mark Schenermanand 5 more
Multiproduct Facility Design and Control for Biologics: Challenges and Considerations logo in a gray background | Multiproduct Facility Design and Control for Biologics: Challenges and Considerations
CMC Forums
Multiproduct Facility Design and Control for Biologics: Challenges and Considerations
Multiproduct Facility Design and Control for Biologics: Challenges and Considerations
Apr 14, 2015
+7
byBo Chi, Julia Edwardsand 7 more
QbD for Biologics: Learning from the Product Development and Realization (A-MAb) Case Study and the FDA OBP Pilot Program logo in a gray background | QbD for Biologics: Learning from the Product Development and Realization (A-MAb) Case Study and the FDA OBP Pilot Program
Process Development
QbD for Biologics: Learning from the Product Development and Realization (A-MAb) Case Study and the FDA OBP Pilot Program
QbD for Biologics: Learning from the Product Development and Realization (A-MAb) Case Study and the FDA OBP Pilot Program
Sep 1, 2012
+8
bySteve Kozlowski, Wassim Nashabehand 8 more
From Pandemics to Bioterrorism logo in a gray background | From Pandemics to Bioterrorism
Economics
From Pandemics to Bioterrorism
From Pandemics to Bioterrorism
Jun 1, 2008
byLorna McLeod

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024